secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tempus AI, Inc. (TEM)
CIK:        0001717115
Form:       8-K
Filed at:   2025-08-08T23:59:59+00:00
Accession:  0000950170-25-105441
Event type: earnings
Sentiment:  positive
Materiality: 0.50
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tempus AI Q2 rev $315M (+90% YoY); raises FY25 guidance to $1.26B, adj EBITDA $5M
--------------------------------------------------------------------------------

- Revenue $314.6M (+89.6% YoY); genomics up 115% to $241.8M; data/services +35.7% to $72.8M.
- Gross profit $195.0M (+158% YoY); net loss improved to ($42.8M) from ($552.2M); adj EBITDA ($5.6M) vs ($31.2M).
- Issued $750M 0.75% convertible notes; cash $293M; FY guidance raised: rev ~$1.26B, adj EBITDA $5M.
- Oncology testing volume +26% YoY; hereditary +32%; >212,000 NGS tests delivered in Q2.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1717115/000095017025105441/0000950170-25-105441-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1717115/000095017025105441/tem-20250808.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-105441

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer